The dynamic field of cardiac testing has never been more promising, with novel markers continuing to find their way into clinical use, an ever-growing body of knowledge surrounding multimarker strategies and the new reality of risk stratification through biomarker testing. In addition, women’s cardiac care is making great strides and the future is bright for proteomic discovery applied to cardiac care.
This conference is designed to provide a comprehensive understanding of the fast advancing field of cardiac markers and its impact on improving patient diagnosis, management and risk assessment through laboratory testing.
The program is designed for those who would like to stay up to date on the ever-changing field of cardiac disease, including laboratorians, physicians, industry reps, consultants and those in related fields. After attending this conference, you’ll understand:
- What ED doctors want most out of cardiac biomarker testing
- The results of a recent report on natriuretic peptides and their role in management
- Why and how women’s cardiac disease needs to be managed
- Recent studies indicating that cardiac markers can guide therapy
- Emerging markers of cardiac risk
- Future efforts in proteomics
This conference features an impressive lineup of speakers and each presentation will conclude with a question-and-answer session. You can get immediate insights from the experts on your most pressing cardiac issues.
AACC designates this program for a maximum of six ACCENT credit hours toward the AACC Clinical Chemist’s Recognition Award and recertification requirements for the NRCC.
To register for this conference, or to get more details, visit http://www.aacc.org/AACC/events/meetings/meetingdetail.htm?id=4272.
|
